Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Role of YAP in lung cancer resistance to cisplatin
Juan Song1, Li-Xia Xie1, Xin-Yi Zhang1
1Department of Respiratory Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Abstract:
Yes-associated protein (YAP) serves a critical role in the initiation and progression of a variety of types of cancer via modulating the expression of genes involved in cell proliferation and the downregulation of apoptosis. Recent studies have suggested that YAP is responsible for the development of drug resistance and cancer metastasis and recurrence. However, the association between YAP and chemoresistance in lung cancer, particularly in lung cancer stem cells (LCSCs) remains largely unknown. In the current study, lung cancer cell spheres were established using the A549 cell line, which demonstrated stem cell properties. It was revealed that YAP was overexpressed in lung cancer spheres compared with normal A549 adherent cells and was associated with enhanced cisplatin (CDDP) resistance. Knockdown of YAP effectively sensitized the adherent A549 and tumor spheres to CDDP treatment and resulted in enhanced cell death. These results suggest that YAP serves a critical role in LCSCs drug resistance and YAP targeting could become a promising adjuvant to current the chemotherapy for lung cancer.
Insights
Yes-associated protein (YAP) drives chemoresistance in lung cancer stem cells. Targeting YAP may enhance chemotherapy effectiveness for lung cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cell Research
Background:
- Yes-associated protein (YAP) is implicated in cancer progression and drug resistance.
- The role of YAP in lung cancer stem cell (LCSC) chemoresistance is not well understood.
Purpose of the Study:
- To investigate the role of YAP in cisplatin resistance in LCSCs.
- To evaluate YAP targeting as a potential therapeutic strategy for lung cancer.
Main Methods:
- Established lung cancer spheres from A549 cells to model LCSCs.
- Assessed YAP expression and its correlation with cisplatin (CDDP) resistance.
- Performed YAP knockdown experiments to determine its effect on CDDP sensitivity.
Main Results:
- YAP was overexpressed in lung cancer spheres compared to adherent cells.
- Overexpressed YAP was associated with enhanced CDDP resistance.
- YAP knockdown sensitized both adherent cells and spheres to CDDP, increasing cell death.
Conclusions:
- YAP plays a significant role in LCSC-mediated chemoresistance.
- Targeting YAP could be a promising adjuvant therapy to improve chemotherapy outcomes in lung cancer.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Lung Capacity
Resistivity
Resistance
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
Equivalent Resistance

